Impact of Cancer on Use of Glucose-Lowering Drug Treatment in Individuals With Diabetes: Potential Mechanisms

Diabetologia - Germany
doi 10.1007/s00125-015-3560-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Impact of Cancer on Adherence to Glucose-Lowering Drug Treatment in Individuals With Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Bromocriptine as a Potential Glucose-Lowering Agent for the Treatment of Prolactinoma With Type 2 Diabetes

Internal Medicine
Internal MedicineMedicine
2019English

Seasonal Variation in Severe Glucose-Lowering Drug-Induced Hypoglycemia in Patients With Type 2 Diabetes

Internal Medicine
Internal MedicineMedicine
2019English

Blood Glucose-Lowering Therapy in Adults With Type 2 Diabetes

Nurse Prescribing
2016English

Changing Patterns of Glucose-Lowering Medication Use in VA Nursing Home Residents With Diabetes, 2005 to 2011

Journal of the American Medical Directors Association
MedicineHealth PolicyGerontologyGeriatricsNursing
2015English

Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006–2014

PharmacoEconomics - Open
Health PolicyPharmacology
2017English

Effects of Intensive Glucose Lowering in Type 2 Diabetes

Yearbook of Endocrinology
2009English

Distinct Glucose-Lowering Mechanisms of Ipragliflozin Depending on Body Weight Changes

Drugs in R and D
Pharmacology
2016English

The Impact of Diabetes Treatment on Survival in a Breast Cancer/Diabetes Model

2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy